Skip to main content
TipRanks
Go Ultimate75% OFF

Nur (NURI) AI Stock Analysis

1 Followers
IL:NURI

Nur

(TASE:NURI)

Select Model
Rating:37Underperform
Price Target:ILA 514.00â–¼(-6.55% Downside)
Action:downgraded
Date:08/26/26

The overall score is at the minimum of 37, reflecting a high-risk profile. The most significant factor is the company's weak financial performance, characterized by unprofitability and a high cash burn rate that threatens its currently stable balance sheet. This is compounded by a strongly bearish technical trend, with the stock in a sustained downtrend across all major moving averages. The negative P/E ratio further confirms the lack of fundamental support for the stock price.

Positive Factors
Revenue reboundThe sharp 2025 revenue rebound shows that the platform has demonstrated some ability to expand its top line from a small base. If sustained, continued revenue growth could improve operating leverage and provide a foundation for rebuilding the company’s earnings profile over coming quarters.
Negative Factors
Persistent unprofitabilityLarge losses despite the revenue rebound indicate that current scale is insufficient to support the cost structure. Continued negative gross and net profitability limits internal funding capacity and leaves the company without demonstrated evidence of a credible near-term path to break-even.

Nur (NURI) vs. iShares MSCI Israel ETF (EIS)

-60%-40%-20%0%20%40%IL:NURI-49.49%EIS+4.94%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
ILS 30.65M
Dividend Yield
―
Average Volume (3M)
7,124
Price to Earnings (P/E)
-3.8
Beta (1Y)
0.85
Revenue Growth
104.30%
EPS Growth
2.80%
Country
Israel
Employees
18
Sector
Basic Materials
Sector Strength
61
Industry
Industrial - Specialties

Nur Business Overview & Revenue Model

Company Description

Nur Ink Innovations Ltd engages in the design, development, and production of water-based pigmented inks for digital inkjet printing applications in Israel. It offers Digital Sol-Gel, a water-based pigment ink for digital printing for direct-to-garme...

Nur Financial Statement Overview

Summary

Financial performance is weak. The Income Statement (Score 15) shows early-stage, unprofitable operations despite strong revenue growth. The Cash Flow Statement (Score 10) indicates a high and unsustainable cash burn rate. The Balance Sheet (Score 40) is the only relative strength, with low debt providing some financial flexibility, but equity is being eroded by ongoing losses. The overall financial health is poor and high-risk.

Income Statement

15Very Negative

Balance Sheet

40Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue380.00K327.00K253.00K000
Gross Profit-3.33M-3.06M-2.69M-1.72M-84-137
EBITDA-8.37M-6.99M-7.56M-11.35K-10.18M-7.07M
Net Income-11.24M-9.42M-9.66M-12.86M-11.61M-7.78M
Balance Sheet
Total Assets20.65M22.74M18.39M21.83K33.29K41.07K
Cash, Cash Equivalents and Short-Term Investments699.00K4.14M5.63M10.44K21.33K32.90K
Total Debt1.89M2.17M2.70M2,6983,1223,507
Total Liabilities6.05M5.84M5.56M5,7585,4815,276
Stockholders Equity14.60M16.90M12.83M16.08K27.80K35.80K
Cash Flow
Free Cash Flow-8.99M-7.85M-7.13M-10.17K-8,094-9,121
Operating Cash Flow-8.56M-7.50M-6.61M-9,316-6,273-6,341
Investing Cash Flow-4.86M-155.00K418.00K485-14.40K-3,309
Financing Cash Flow13.12M10.04M5.22M-447-38542.39K

Nur Technical Analysis

Technical Analysis SentimentNegative
Last Price550.00

Price Trends

50DMA632.86Negative
100DMA718.66Negative
200DMA872.81Negative

Market Momentum

MACD-20.75Positive
RSI29.77Positive
STOCH85.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NURI, the sentiment is Negative. The current price of 550.00 is below the 20-day moving average (MA) of 598.41, below the 50-day MA of 632.86, and below the 200-day MA of 872.81, indicating a bearish trend. The MACD of -20.75 indicates Positive momentum. The RSI at 29.77 is Positive, neither overbought nor oversold. The STOCH value of 85.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:NURI.

Nur Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IL:NURI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:NXSNIL:NXSN71OutperformILS 16.32B25.49―0.93%77.04%55.80%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IL:PHTMIL:PHTM44NeutralILS 35.62M-3.37――12.14%43.83%
IL:MSVTIL:MSVT42NeutralILS 23.13M-0.36――-40.18%67.38%
IL:NURIIL:NURI37UnderperformILS 48.50M-3.82――104.30%2.80%
IL:SCDXIL:SCDX32UnderperformILS 25.84M-1.53――-38.60%-428.31%

* Basic Materials Sector Average

Performance Comparison

0%100%IL:NURIIL:VISNIL:SCDXIL:PHTMIL:MSVTIL:NXSNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IL:NURI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:NURINUR INK INNOVATIONS LTD550.00-539.00-49.49%
IL:VISNVision Sigma Ltd3843.00-1878.00-32.83%
IL:SCDXScodix Ltd.75.40-170.36-69.32%
IL:PHTMPhotomyne Ltd1322.00-867.00-39.61%
IL:MSVTMASSIVIT 3D PRINTING TECHNOLOGIES LTD33.30-42.40-56.01%
IL:NXSNNextVison Stabilized Systems, Ltd.17940.003640.0025.45%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 26, 2026